EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $782 | +0.3% | 27,562 | +3.3% | 0.02% | 0.0% |
| Q4 2022 | $780 | -99.9% | 26,675 | +24.2% | 0.02% | +21.4% |
| Q3 2022 | $567,000 | -40.6% | 21,475 | 0.0% | 0.01% | -36.4% |
| Q2 2022 | $954,000 | -78.9% | 21,475 | -76.5% | 0.02% | -75.6% |
| Q1 2022 | $4,530,000 | -20.9% | 91,534 | -18.7% | 0.09% | -6.2% |
| Q4 2021 | $5,730,000 | -6.3% | 112,534 | +2.7% | 0.10% | -12.7% |
| Q3 2021 | $6,114,000 | +157.0% | 109,604 | +97.2% | 0.11% | +161.9% |
| Q2 2021 | $2,379,000 | – | 55,594 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |